# Real-world Study on the Effectiveness and Safety of Control-IQ Technology in Teenagers With Type 1 Diabetes Engaging in Regular Physical Activity

> **NCT06876207** · — · RECRUITING · sponsor: **Bruno Bombaci** · enrollment: 50 (estimated)

## Conditions studied

- Type 1 Diabetes Mellitus

## Interventions

- **DEVICE:** Tandem t:slim X2 with Control-IQ technology

## Key facts

- **NCT ID:** NCT06876207
- **Lead sponsor:** Bruno Bombaci
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-06-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-06-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06876207

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06876207, "Real-world Study on the Effectiveness and Safety of Control-IQ Technology in Teenagers With Type 1 Diabetes Engaging in Regular Physical Activity". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06876207. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*